FREE Case Review (866) 588-0600

Viagra Melanoma Litigation Proceeding in California

Since the creation of the federal multidistrict litigation for lawsuits alleging melanoma skin cancer from Viagra, there have been several orders relating to the overall management of the claims.

Since the creation of the federal multidistrict litigation (MDL) for lawsuits alleging melanoma skin cancer from the erectile dysfunction drug Viagra (sildenafil), there have been several orders relating to the overall management of the claims.

Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with melanoma after taking Viagra, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

September 30, 2016 – U.S. District Judge Richard G. Seeborg, who is overseeing the Viagra litigation (MDL No. 2691), has held 2 hearings since the creation of the MDL, the first on June 15 and the second on August 10.

The hearings covered various administrative and management issues for the litigation, including:

  • Providing the judge with an update on the individual Viagra lawsuits filed so far;
  • A discussion of how to handle complaints that involve “mixed use” (in which Viagra was taken in conjunction with another ED drug such as Cialis (tadalafil), and
  • Using master pleadings to expedite the MDL and conserve the resources of all parties involved in the litigation.

About 50 Viagra melanoma lawsuits have been centralized in the MDL to date, but it is anticipated that the litigation will eventually grow to include hundreds or even thousands of cases. In addition to the federal complaints, at least 70 individual lawsuits have been filed in state court in St. Louis, Missouri on behalf of cancer patients.

Seeborg has also ordered a briefing on a number of issues related to first discovery, including a pending dispute over methods to be used for electronically stored information (ESI), which is related to searching and producing Pfizer’s digital and electronic data. This is critical in determining liability issues and providing evidence that plaintiffs must gather to prove their cases.

The complaints allege that studies have demonstrated Viagra blocks of the secretion of PDE5, which leads to an increase of cycle guanosine monophosphate (cGMP) in the body. Elevated levels of cGMP have been associated with cell mutation and the creation and proliferation of melanoma cells, according to the lawsuits.

The fact and liability discovery phase of the MDL will include the production of millions of pages of documents from Pfizer and third parties spanning over two decades of research and development, FDA approval, marketing, and safety surveillance. During the discovery phase, which typically takes between 12 and 24 months, the parties will compose depositions of fact witnesses involved in the development, marketing and safety monitoring of Viagra.

The next hearing in the Viagra litigation is scheduled for Oct. 14. By then the initial discovery issues should be resolved so that the production of documents by Pfizer can begin. Seeborg will probably announce a timetable for completing discovery and preparation for the first bellwether trials at the hearing. Drug and medical device cases coordinated through the MDL process usually take about 3 years to complete.

Do I Have a Viagra Melanoma Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Viagra lawsuits. We are handling individual litigation nationwide and currently accepting new melanoma cases in all 50 states.

Free Case Evaluation: Again, if you got melanoma after taking Viagra, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition